Clinical Trial Update: Phase 2 Study of TR-701 in Patients With Complicated Skin and Skin Structure Infections [Phase 2]

View source ↗

Summary

Phase 2 study of TR-701 for complicated skin and skin structure infections completed; results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infectious Diseases
• Skin Diseases
• Skin Diseases Bacterial

Drugs mentioned

• TR-701

Snippet

Sponsor: Trius Therapeutics LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | Conditions: Skin Diseases, Infectious, Skin Diseases, Bacterial | Phase 2 | Status: COMPLETED | Results posted: 2014-08-07